Edition:
United States

Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

1.16USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.16
Open
$1.17
Day's High
$1.18
Day's Low
$1.15
Volume
2,839,238
Avg. Vol
6,071,376
52-wk High
$2.47
52-wk Low
$0.73

Select another date:

Tue, Aug 8 2017

BRIEF-Novavax Q2 loss per share $0.16

* Q2 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Novavax reports Q2 loss per share $0.16

* Q2 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

BRIEF-Novavax announces positive topline data from phase 2 trial and provides path forward for RSV F vaccine programs

* Novavax announces positive topline data from phase 2 older adult trial and provides path forward for RSV F vaccine programs Source text for Eikon: Further company coverage:

BRIEF-Novavax reports Q1 loss per share $0.16

* Q1 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S

BRIEF-Novavax reports Q1 loss per share $0.16

* Q1 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Select another date: